Mikhail Reibarkh

Mikhail Reibarkh

Central US Merck & Co., Inc. - Kenilworth / United States
Others
AD Scientific Index ID: 4376520
-
person_outline Mikhail Reibarkh's MOST POPULAR ARTICLES
1-) Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4GNJ Moerke, H Aktas, H Chen, S Cantel, MY Reibarkh, A Fahmy, JD Gross, ...Cell 128 (2), 257-267, 20075692007
2-) Small molecule inhibition of phosphatidylinositol-3, 4, 5-triphosphate (PIP3) binding to pleckstrin homology domainsB Miao, I Skidan, J Yang, A Lugovskoy, M Reibarkh, K Long, T Brazell, ...Proceedings of the National Academy of Sciences 107 (46), 20126-20131, 20101532010
3-) Selective pharmacological targeting of a DEAD box RNA helicaseL Lindqvist, M Oberer, M Reibarkh, R Cencic, ME Bordeleau, E Vogt, ...PloS one 3 (2), e1583, 20081392008
4-) A multifunctional catalyst that stereoselectively assembles prodrugsDA DiRocco, Y Ji, EC Sherer, A Klapars, M Reibarkh, J Dropinski, ...Science 356 (6336), 426-430, 20171482017
5-) Oxyfunctionalization of the remote C− H bonds of aliphatic amines by decatungstate photocatalysisDM Schultz, F Lévesque, DA DiRocco, M Reibarkh, Y Ji, LA Joyce, ...Angewandte Chemie International Edition 56 (48), 15274-15278, 20171302017